S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

EWTX Edgewise Therapeutics Inc

29.66

0.16 (0.54%)

Last Updated: 04:58:15

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Edgewise Therapeutics (NASDAQ:EWTX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Edgewise Therapeutics Charts.

Edgewise Therapeutics (NASDAQ:EWTX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Edgewise Therapeutics Charts.

Edgewise Therapeutics Inc News

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Tuesday 4 February 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Friday 24 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 23 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development
Thursday 23 January 2025 (2 weeks ago) • Business Wire

Edgewise Therapeutics Provides Corporate Update and Highlights Priorities for 2025
Tuesday 14 January 2025 (3 weeks ago) • Business Wire

Edgewise Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025
Wednesday 8 January 2025 (4 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 1 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 31 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 17 December 2024 (2 months ago) • Edgar (US Regulatory)

Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker)
Monday 16 December 2024 (2 months ago) • Business Wire

Edgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research
Friday 6 December 2024 (2 months ago) • Business Wire

More Edgewise Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions